Brinsupri

Active Ingredient(s): Brensocatib
FDA Approved: * August 12, 2025
Pharm Company: * INSMED INC
Category: Lungs (Pulmonary)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Brinsupri 10 mg Oral Tablet
NDC: 71558-001
Labeler:
Insmed Incorporated
Brinsupri 25 mg Oral Tablet
NDC: 71558-002
Labeler:
Insmed Incorporated